Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma

Giovanni Riva, Ivana Lagreca, Adriana Mattiolo, Daniela Belletti, Laura Lignitto, Patrizia Barozzi, Barbara Ruozi, Daniela Vallerini, Chiara Quadrelli, Giorgia Corradini, Fabio Forghieri, Roberto Marasca, Franco Narni, Giovanni Tosi, Flavio Forni, Maria Angela Vandelli, Alberto Amadori, Luigi Chieco-Bianchi, Leonardo Potenza, Maria Luisa CalabròMario Luppi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)e467-e470
JournalHaematologica
Volume100
Issue number11
DOIs
Publication statusPublished - Oct 31 2015

Keywords

  • BLIMP1/PRDM1
  • Liposomes
  • PEL
  • RNAi
  • siRNA

ASJC Scopus subject areas

  • Hematology

Cite this

Riva, G., Lagreca, I., Mattiolo, A., Belletti, D., Lignitto, L., Barozzi, P., Ruozi, B., Vallerini, D., Quadrelli, C., Corradini, G., Forghieri, F., Marasca, R., Narni, F., Tosi, G., Forni, F., Vandelli, M. A., Amadori, A., Chieco-Bianchi, L., Potenza, L., ... Luppi, M. (2015). Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma. Haematologica, 100(11), e467-e470. https://doi.org/10.3324/haematol.2015.126854